Revised: 7 November 2019
Information for Healthcare Professionals
This section provides information useful to healthcare professionals.
Medsafe Advice
| Date | Type | Title |
|---|---|---|
| 13/5/2022 | Consultation | Review of Fees payable under the Medicines Act 1981 |
| 11/5/2022 | COVID-19 | Adverse events following immunisation with COVID-19 vaccines: Safety Report #43 – 30 April 2022 |
| 24/4/2022 | Medicines | Minor Guidelines update: Part 4: Manufacture of Medicines: |
| 14/4/2022 | Committees | Reports from the 189th Medicines Adverse Reactions Committee Meeting |
| 14/4/2022 | Committees | Minutes of the 189th Medicines Adverse Reactions Committee Meeting |
| 13/4/2022 | COVID-19 | Adverse events following immunisation with COVID-19 vaccines: Safety Report #42 – 31 March 2022 |
| 10/4/2022 | Committees | Comments on agenda items for the 68th meeting of the Medicines Classification Committee to be held on 26 April 2022 |
| 8/4/2022 | Alert Communication | Reminder: Miracle Mineral Solution has dangerous and potentially life-threatening side effects |
| 5/4/2022 | Dear Healthcare Professional Letter | Supply of PAXLOVID (nirmatrelvir 150 mg/ritonavir 100 mg), film coated tablets |
| 30/3/2022 | Committees | Reclassification of Pholcodine |
If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.
